Atlas FDA

Therakos CELLEX Procedural Kit

FDA premarket approval P860003/S101 · decided 2019-05-13

Approval details

PMA number
P860003
Supplement
S101
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Therakos CELLEX Procedural Kit
Generic name
System, photopheresis, extracorporeal
Applicant
Therakos Development Limited
Date received
2019-02-12
Decision date
2019-05-13
Days to decision
90 days
Decision code
APPR
Product code
LNR
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Dublin
Statement
Approval for design changes to the pump tubing organizer assembly of the Therakos CELLEX Procedural Kit.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.